Last reviewed · How we verify

NCT04959591

Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery

Completed Phase 3 Last updated 28 December 2022
What this trial tests

Phase 3 trial testing intravenous acetaminophen in Scoliosis; Adolescence in 99 participants. Completed in 22 April 2022.

Timeline
1 June 2021
Primary endpoint
15 April 2022
22 April 2022

Quick facts

Lead sponsorAsan Medical Center
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment99
Start date1 June 2021
Primary completion15 April 2022
Estimated completion22 April 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Asan Medical Center

Who can join

Adults 11 to 20, any sex, with Scoliosis; Adolescence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of preemptive and preventive intravenous acetaminophen on opioid consumption in pediatrics undergoing posterior spinal fusion surgery: a randomized controlled trial.
    Kim YJ, Kim HJ, Kim S, Kim H, et al · · 2024 · cited 1× · PMID 38383005 · DOI 10.4097/kja.23747

Verify or expand the search:

Other recruiting trials for Scoliosis; Adolescence

Currently open trials in the same condition.

Other Asan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04959591.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing